You are here

CDMOs

Biopharma prepares to pivot from China as Biosecure Act advances

Pharma Voice

Mon, 09/16/24 - 09:48 am

Complete Genomics

After sharp declines, Merck KGaA and analysts share optimism about potential CDMO rebound

Fierce Pharma

Wed, 08/7/24 - 11:00 pm

Scrutiny of WuXi Raises Potential Opportunities for Indian CDMOs

BioSpace

Wed, 07/3/24 - 11:18 am

Vanda rejects buyout offers, pans 'opportunistic attempts' at securing its shares at a discount

Fierce Pharma

Thu, 06/20/24 - 11:42 am

Vanda Pharmaceuticals

Cycle Pharmaceuticals

CordenPharma and Certest forge partnership to enhance drug delivery innovations

Biopharma Reporter

Mon, 06/10/24 - 11:21 am

Would BIO support a biosecurity bill targeting drug developers? Hear CEO John Crowley’s response

Fierce Pharma

Sun, 06/9/24 - 11:31 pm

Three Indian CDMOs ready to seize the BIOSECURE Act opportunity

Biopharma Reporter

Thu, 06/6/24 - 11:24 am

Merck KGaA's CDMO unit continues to slide but company sees an uptick coming

Fierce Pharma

Wed, 05/15/24 - 10:50 pm

Lonza, busy with capacity upgrades and exec turnover, hints at CDMO industry rebound

Fierce Pharma

Tue, 05/14/24 - 11:38 am

CDMO Fujifilm Diosynth's restructuring plan may leave up to 240 staffers out of work

Fierce Pharma

Wed, 04/17/24 - 10:04 pm

Fujifilm Diosynth Biotechnologies

Lonza adds biologics capacity with $1.2bn Roche deal

Pharmaphorum

Wed, 03/20/24 - 11:17 am

drug manufacturing

Despite pharma growth, Merck KGaA's CDMO slowdown plays into company's overall sales decline

Fierce Pharma

Sun, 03/10/24 - 08:40 pm

Evotec Biologics expands partnership with ABL to develop antibodies against HIV

Biopharma Reporter

Mon, 02/12/24 - 11:10 pm

Evotec Biologics

As Catalent prepares to join Novo family, CDMO's sales continue to slide

Fierce Pharma

Fri, 02/9/24 - 11:21 am

With record year, Samsung Biologics bucks CDMO industry's troublesome 2023

Fierce Pharma

Thu, 01/25/24 - 11:24 am

Samsung BioLogics

drug manufacturing

Naobios receives $1.87 million to fund human viral challenge agent

Biopharma Reporter

Mon, 12/11/23 - 10:14 am

Gates Foundation

High-flying Fujifilm splashes $200M to beef up cell therapy capacity

Fierce Pharma

Mon, 12/4/23 - 06:08 pm

J&J books manufacturing space at Fujifilm Diosynth's upcoming mega-plant in North Carolina

Fierce Pharma

Wed, 11/8/23 - 09:57 pm

Fujifilm Diosynth Biotechnologies

Lonza expands antibody-drug conjugate production pact, plots 180 new hires

Fierce Pharma

Thu, 10/5/23 - 10:09 am

Bluebird taps Lonza to boost manufacturing capacity for its gene therapies Zynteglo, Skysona

Fierce Pharma

Thu, 09/28/23 - 10:27 am

drug manufacturing

Pages